Brain protection during open heart surgery in the neonate and infant remains inadequate. Effects of the excitatory neurotransmitter antagonists MK-801 and NBQX on recovery of brain cellular energy state and met abolic rates were evaluated in 34 4-week-old piglets (10 MK-801, 10 NBQX, 14 controls) undergoing cardiopul monary bypass and hypothermic circulatory arrest at 15°C nasopharyngeal temperature for 1 h, as is used clin ically for repair of congenital heart defects. MK-801 (di zocilpine) (0.75 mg/kg) or NBQX [2,3-dihydroxy-6-nitro-7-sulfamoyl-benzo(F)quinoxaline] (25 mg/kg) was given intravenously before cardiopulmonary bypass. Equiva lent doses were placed in the cardiopulmonary bypass prime plus continuous infusions after reperfusion (0.15 mg kg-1h-1 and 5 mg kg-1h -I ) . Changes in high-energy phosphate concentrations and pH were analyzed by mag netic resonance spectroscopy in 17 animals until 225 min after reperfusion. Cerebral blood flow determined by ra dioactive microspheres as well as cerebral oxygen and glucose consumption were studied in 17 other animals. Cerebral blood flow and oxygen consumption were de-Over the last decade, the surgical mortality for repair of congenital heart defects has declined dra matically. In addition, there has been a trend to Abbreviations used: AMPA, a-amino-3-hydroxy-5-methyl-4isoxazole; ANOVA, analysis of variance; AV, arteriovenous; CPB, cardiopulmonary bypass; NBQX, 2,3-dihydroxy-6-nitro-7sulfamoyl-benzo(F)quinoxaline; MANDV A, multivariate analy sis of variance; NMDA, N-methyl-D-aspartate.
Summary:
Brain protection during open heart surgery in the neonate and infant remains inadequate. Effects of the excitatory neurotransmitter antagonists MK-801 and NBQX on recovery of brain cellular energy state and met abolic rates were evaluated in 34 4-week-old piglets (10 MK-801, 10 NBQX, 14 controls) undergoing cardiopul monary bypass and hypothermic circulatory arrest at 15°C nasopharyngeal temperature for 1 h, as is used clin ically for repair of congenital heart defects. MK-801 (di zocilpine) (0.75 mg/kg) or NBQX [2,3-dihydroxy-6-nitro-7-sulfamoyl-benzo(F)quinoxaline] (25 mg/kg) was given intravenously before cardiopulmonary bypass. Equiva lent doses were placed in the cardiopulmonary bypass prime plus continuous infusions after reperfusion (0.15 mg kg-1h-1 and 5 mg kg-1h -I ) . Changes in high-energy phosphate concentrations and pH were analyzed by mag netic resonance spectroscopy in 17 animals until 225 min after reperfusion. Cerebral blood flow determined by ra dioactive microspheres as well as cerebral oxygen and glucose consumption were studied in 17 other animals. Cerebral blood flow and oxygen consumption were de-Over the last decade, the surgical mortality for repair of congenital heart defects has declined dra matically. In addition, there has been a trend to pressed relative to control by both MK-801 and NBQX at baseline. Recovery of phosphocreatine (p = 0.010), ATP (p = 0.030), and intracellular pH (p = 0.004) was accel erated by MK-801 and retarded by NBQX over the 45 min of rewarming reperfusion and the first hour of normo thermic reperfusion. The final recovery of ATP at 3 h and 45 min reperfusion was significantly reduced by NBQX (46 ± 26% baseline, mean ± SD) versus control (81 ± 19%) and MK-801 (75 ± 8%) (p = 0.030). Cerebral oxy gen consumption recovered to 105 ± 30% baseline in group MK-801 and 94 ± 31% in control but only to 61 ± 22% in group NBQX (p = 0.070). Cerebral blood flow stayed significantly lower in group NBQX relative to con trol. Thus, MK-801 accelerates recovery of cerebral high energy phosphates and metabolic rate after cardiopulmo nary bypass and hypothermic circulatory arrest in the immature animal. At the dosage used NBQX exerts an adverse effect. Key Words: Excitatory neurotransmitter antagonist-Ischemia-Magnetic resonance spectros copy-Hypothermia-Immature-Heart surgery. perform primary repair in the neonatal period and early infancy (Castaneda et aI., 1984 (Castaneda et aI., , 1989 Di Do nato et aI., 1991) . Increasing attention has been fo cused on the quality of life of those patients surviv ing surgery. Open heart surgery in the neonate and infant often requires cessation of total body perfu sion for precise operation in a very small heart or because of aortic arch and/or venous return anom alies. Currently, deep systemic hypothermia « 18°C) is the only major strategy employed for protection of the brain and systemic organs during this total body ischemia. However, hypothermia alone does not provide satisfactory cerebral protec tion during relatively long (>45 min) periods of cir culatory arrest (Kirklin and Barratt-Boyes, 1992) . Neurologic abnormalities, including seizures and developmental delay, are reported in neonates and infants after hypothermic circulatory arrest (Ferry, 1990) . Another characteristic complication in in fants is choreoathetosis (Brunberg et aI., 1974; Wong et aI., 1992) . This topologically selective vul nerability suggests involvement of excitatory amino acid transmitters (Greenamyre et aI., 1987; Barks et aI., 1988) . Recent animal studies of normothermic global cerebral ischemia (Simon et aI., 1984; Gill et aI., 1987; Hattori et aI., 1989; Sheardown et aI., 1990; Nellgard and Wieloch, 1992) have suggested that blockade of excitatory amino acid receptors may improve neurologic outcome. In order to ex plore possible application of excitatory amino acid antagonists to brain protection during deep hypo thermic circulatory arrest, the effects of MK-801 (dizocilpine) and NBQX [2,3-dihydroxy-6-nitro-7sulfamoyl-benzo(F)quinoxaline] on recovery of ce rebral blood flow and metabolism were studied in an immature piglet model which replicates deep hy pothermic circulatory arrest as employed clinically at our institution for repair of congenital heart de fects in neonates and infants.
MATERIALS AND METHODS
Thirty-four Yucatan miniature piglets, 27-31 (mean 29) days old, weighing 2.3-4.8 (mean 3.7) kg (Charles River Laboratories, Wilmington, MA, U.S.A.) were studied in compliance with the "Principles of Laboratory Animal Care" formulated for the National Society for Medical Research and the "Guide for the Care and Use of Labo ratory Animals" prepared by the National Academy of Science (NIH Publication No. 86-23, revised, 1985) . The animals were obtained 1-2 days before the study and fasted for 12 h before surgery.
Blood flow and metabolism studies
Experimental preparation. In 17 piglets, cerebral met abolic rates and cerebral and systemic blood flows by radioactive microspheres were studied using techniques which have been described in detail (Kawata et ai., 1993) previously and are summarized here. The animals were anesthetized with intraperitoneal injection of methohexi tal (40 mg/kg), tracheally intubated, and then ventilated with 100% oxygen by a Harvard ventilator to achieve an arterial Pc02level between 35 and 45 mm Hg. Venous and arterial catheters were inserted through the surgically ex posed right femoral vein and artery into the thoracic in ferior vena cava and aorta, respectively. After a bolus intravenous injection of 20 I-lg/kg of fentanyl and 0.3 mgl kg of pancuronium, anesthesia was maintained with con tinuous infusions of fentanyl (25 I-lg kg-1h-l) and pancu-ronium (0.1 mg kg-1h-I). The animal's temperature was monitored throughout the study by rectal and nasopha ryngeal temperature probes. The temperature was main tained at > 35°C before cardiopulmonary bypass (CPB) by means of a heating lamp. The ECG and arterial and ve nous pressures were continuously monitored. A bladder catheter was placed to monitor urine output.
The heart was exposed through a median sternotomy incision. Pericardial traction sutures were avoided so as not to compromise venous drainage. A 5 French sampling catheter was inserted through the right internal jugular vein in a retrograde direction to the level of the jugular bulb. The piglet was fully heparinized (300 IUlkg), and a 10 French arterial and a 20-24 French venous cannula were inserted through a purse string suture in the ascend ing aorta and into the right atrial appendage, respectively, for institution of CPB. The pump-oxygenator system con sisted of a roller pump and a Bio-2 infant bubble oxygen ator (Bentley Laboratories Inc, Irvine, CA, U.S.A.). The venous drainage was accomplished by gravity. No arte rial filter was used. Shed blood in the operating field after systemic heparinization was returned to the system through a 20-l-lm transfusion filter. An electromagnetic flow probe (FF-060T, Nihon Kohden, Tokyo, Japan) was placed in the arterial perfusion circuit to verify the pump flow. The pump-oxygenator system was primed with 400 ml homologous blood collected 2 days before the study (Charles River Laboratories) and 350 ml of Normosol R pH 7.4 (Abbott Laboratories, North Chicago, IL, U.S.A.) to achieve a hematocrit of 20-25%. Methylpred nisolone 30 mg/kg, cephazolin sodium 25 mg/kg, and so dium bicarbonate to achieve a pH of 7.4 were added to the prime. Normosol R pH 7.4 heparinized with 2,500 lUlL was used when there was a decrease in reservoir volume during CPB. Temperature of the perfusate was controlled by the heat exchanger within the oxygenator and a water bath system warmed by a thermostat controlled heater-circulator except during the cooling phase when ice water was circulated.
Perfusion protocol. Bypass flow was set at 150 ml kg -Imin -1 calibrated at a perfusate temperature of 37°C except for the period of circulatory arrest. Cooling of the perfusate resulted in 15-20% decrease in pump flow mea sured by the electromagnetic flowmeter, but the flow was not adjusted. The "alpha stat" strategy of pH manage ment (Kirklin and Barratt-Boyes, 1992) was accom plished by adjusting the oxygen flow to the oxygenator. No adjustment was made for the natural alkaline shift in pH resulting from hypothermia. The piglet was perfused for 20 min at normothermia (37°C arterial temperature) to stabilize body temperature between 36.3 and 36.7°C and correct any minor metabolic deficits which may have oc curred during the preparatory phase. Lung ventilation was stopped at the initiation of CPB and the ventilator was disconnected.
Baseline measurements. These were made at the end of the stabilizing period. Then, the perfusate was cooled to an arterial temperature of 13°C, maintaining a tempera ture gradient of < lOoC between blood and nasopharyn geal temperature. Ice packs were placed around the head throughout the cooling and circulatory arrest periods. Af ter 30 min of perfusion cooling, when nasopharyngeal temperature was 14.0-15.0°C, perfusion was stopped for 1 h. The animal was exsanguinated through the venous drainage line. No cardioplegic solution was given. Reper fusion was begun at 150 ml kg -Imin -I with the perfusate at room temperature (20-25°C). The perfusate was then rewarmed to 37°C by circulating warm water (up to 40°C) to the oxygenator. Boluses of 0.2 mg/kg of phentolamine were given at the beginning of both the cooling and re warming periods to avoid vasoconstriction and to mini mize temperature gradients, as is done clinically. Normo thermia was achieved within 45 min in all animals. After 45 min of rewarming reperfusion, lung ventilation was restarted at the same ventilator settings as used in the prebypass period. The pump perfusion was continued for 3 more hours with the blood temperature at 37°C until the last measurements were made. During the last 3 h of nor mothermic perfusion, pulsatile assistance from the heart was achieved by minimally «5 mm Hg) raising central venous pressure. At the end of study, the animal was killed by a bolus injection of Beuthanasia (Schering, Ke nilworth, NJ, U.S.A.) and potassium chloride into the bypass circuit.
Data collection. Blood flow measurement. Regional blood flow to the brain and systemic organs was mea sured by the radioactive microsphere technique (Hey mann et aI., 1977) at 20 min after initiation of normother mic CPB (baseline), at 30 min into cooling, and at 5 min, 45 min, and 225 min after reperfusion. Microspheres (15-fLm diameter) labeled with one of the following radioac tive nuciides-1 2 5I, 141Ce, 113 Sn, 85Sr, 95Nb, 46SC_ suspended in 0.5 ml of lO% dextran were injected into a side port on the arterial tubing 50 cm from the tip of the arterial cannula to ensure complete mixing. Each micro sphere injection consisted of approximately 2.5 x 106 mi crospheres. A measured quantity of blood (�5 mO as ref erence was withdrawn at a constant rate by a syringe pump (model 2603, Harvard Apparatus) from the arterial monitoring line placed in the thoracic aorta. Arterial blood was withdrawn during and until 30 s after comple tion of the microsphere injection. At termination of the experiment, the brain, heart, lungs, kidneys, liver, adre nals, and intestines were removed and weighed. The brain was divided into five parts, i.e., the cerebral hemi spheres, basal ganglia, midbrain, cerebellum, and brain stem (pons and medulla oblongata). The organs were dis solved in 2 N KOH-methanol solution, and the radioac tivity was counted with a gamma counter (Compugamma 1282, LKB Int., Wallac, Finland) with a spillover correc tion between the nuclides. The reference blood was also analyzed for radioactivity. The regional blood flow was calculated from the rate of withdrawal of the reference blood and the ratio of the radioactivity of the organ to the reference blood. The total systemic flow calculated from the total radioactivity in each injection and the reference blood correlated well with the pump flow measured by the electromagnetic flowmeter (y = 0.97x + 18.2 r = 0.9223; p < 0.001). Metabolic measurements. Blood gas tensions and pH, hemoglobin, plasma glucose, and lactate levels were mea sured in both arterial and jugular venous blood before CPB and after each microsphere injection. Blood gas and hemoglobin were measured with a blood gas analyzer (Model 278, Ciba Corning). Plasma glucose and lactate levels were determined by glucose oxidase method and enzymatic fluorometric micromethod, respectively. Cere bral oxygen consumption and cerebral glucose consump tion were calculated from the difference between the ar terial and internal jugular venous oxygen contents, glu cose concentrations, and total cerebral blood flow. The oxygen content was calculated by the formula:
Magnetic resonance spectroscopy study Experimental preparation. Another set of 17 animals underwent the same surgical procedure and CPB as de scribed for the blood flow and metabolism studies. They underwent 31p magnetic resonance spectroscopy study in an Oxford horizontal bore superconducting 4.7 T magnet, as described previously in detail (Kawata et al., 1993) . A 3.0-cm diameter copper surface coil was sutured onto the scalp overlying the cerebral hemispheres. After place ment, the coil was matched and tuned to the phosphorus frequency. Arterial and venous lines were inserted for blood gas measurement and drug infusion, but no instru mentation for metabolic or blood flow measurements was applied. All ferromagnetic surgical instruments were re moved or substituted with plastic equivalents before plac ing in the magnet.
Data collection. 31p magnetic resonance spectra were acquired in the Fourier transform mode on a custom-built spectrometer. The field homogeneity was optimized using the brain water signal. Spectra were acquired using a 90° excitation pulse of 60 fLS. Each spectrum was the average of 64 (5 min) or 128 (9 min) acquisitions. Peak areas of inorganic phosphate (Pi)' creatine phosphate (P Cr) , and f3 nucleoside triphosphate were determined by Lorentzian curve fitting and peak integration. Changes in ATP con centration were assessed from the f3 nucleoside triphos phate peak. The Pi' PCr' and ATP data are reported as percentage of the full flow normothermic baseline data at 20 min on bypass. The brain intracellular pH (pHJ was calculated from the chemical shift of the Pi peak relative to the PCr peak (D), using the following equation:
where pK' = 6.700, Da = 3.148, Db = 5.695 for a tem perature of 37°C, and pK' = 6.780, Da = 3.227, Db = 5.653 for 15°C (Kost, 1990) . The equation for 15°C was used to calculate the pHi at the end of perfusion cooling, and the equation for 37°C was used for all other spectra.
Brain water content. The skull was opened with an os cillating brain saw. The cranial nerves and spinal cord were divided and the dura was opened. The brain was removed whole. It was placed on a plastic sheet and di vided into right and left cerebrum, basal ganglia, mid brain, cerebellum, and lower brainstem. After extra mois ture on the surface was blotted with gauze, each part was weighed with a balance (AEI00, Mettler Instruments, Switzerland) immediately after the experiment (wet weight) and again after desiccation for 72 h at 60°C (dry weight). Organ water fraction was calculated as (wet weightdry weight)/(wet weight).
Experimental groups
For the blood flow and metabolic study, five piglets received 0.75 mg/kg of MK-801 intravenously 5 min be fore initiation of CPB with 1.5 mg/kg in the CPB prime and continuous infusion (0.15 mg kg-1h-1) during reper fusion. Another group of five piglets had NBQX (25 mg/ kg) intravenously before CPB with 25 mg/kg in the CPB prime and continuous infusion during reperfusion (5 mg kg-1h-1). The other seven piglets served as controls.
For the magnetic resonance spectroscopy study, five piglets had MK-801, five had NBQX, and seven served as 
Statistics
All values are reported as mean ± standard deviation (SD) and were analyzed by means of a statistical analysis system (SPSS, SPSS Inc., Chicago, IL, U.S.A.). Data were analyzed with repeated measures analysis of vari ance (ANOYA); the paired t test was used to detect dif ferences within a group and one-way ANOY A and the Student-Newman-Keuls test were used to detect differ ences between groups. (Table 1 and Fig. 1) There were no significant differences among the three groups in arterial P02 and Pco2, hematocrit level, and nasopharyngeal and rectal temperatures at any measurement. Blood pressure was signifi cantly different at 60 min in each treated group com pared with controls after normothermia (MK-801: 112 ± 9 mm Hg, control: 93 ±7 mm Hg, NBQX: 72 ± 14 mm Hg; p < 0.001) and at 120 min after nor mothermia (MK-801: 134 ± 8 mm Hg, control: 115 ± 9 mm Hg, NBQX: 89 ± 16 mm Hg; p < 0.001). Four of the 10 animals which received NBQX showed a fall in blood pressure by 45-50 mm Hg within 1-2 min after the injection but subsequently recovered with some volume infusion. The hearts were noted to be stained yellow in the NBQX ani mals.
RESULTS

Experimental conditions
Cerebral high-energy phosphates and intracellular pH (Fig. 2) Administration of the drugs and initiation of nor mothermic CPB did not affect the prebypass values of ATP, P Cr or pHj. Both ATP and P Cr increased and pHj became more alkaline during cooling in all groups. The ATP, P Cro and pHj values were 123 ± 16% of normothermic CPB baseline, 127 ± 8% of normothermic CPB baseline, and 7.63 ± 0.15 (7.08 ± 0.06 at baseline) in the control group, 111 ± 13%, 124 ± 24%, and 7.54 ± 0.17 (7.10 ± 0.02 at baseline) in the MK-801 group, and 124 ± 8%, 129 ± 17%, and 7.57 ± 0.26 (7.13 ± 0.09 at baseline) in the NBQX group, respectively, immediately before cir culatory arrest. There were no significant differ ences between groups in these values.
ATP and P Cr decreased to an immeasurable quan- 36. 3 ± 0. 9 36. 4 ± 0. 5 37.1 ± 0.5 35. 9 ± 1.1 36.5 ± 0. 5
Prebypass, before venous cannulation and initiation of cardiopulmonary bypass; CPB(20), 20 min after initiation of cardiopulmonary bypass; RP(O), just before reperfusion; RP(5), 5 min after initiation of reperfusion and rewarming; NT(O), after 45 min of rewarmingl reperfusion; NT(180), after 180 min of normothermic reperfusion following 45 min of rewarming/reperfusion. tity within 36 min during circulatory arrest. pHj be came acidotic during circulatory arrest but was not measurable in most of the cases during the latter 40 min of circulatory arrest and the initial 9 min of reperfusion because of insufficient PCr peaks. The mean recovery rate of ATP (p = 0.030) was significantly accelerated during the first 15 min of reperfusion in the MK-801 group (4.24 ± 0.59%/ min) compared with both the control group (2.08 ± 1.83%/min) and the NBQX group (1.75 ± 1.25%/ min). The mean recovery rate of ATP (p = 0.010), PCr (p = 0.030), and pHj (p = 0.004) was signifi cantly retarded during the first 105 min (45 min of rewarming plus 60 min of normothermia) of reper fusion in the NBQX group (ATP: 0.42 ± 0.26%/min, J Cereb Blood Flow Metab, Vol. 14, No.1, 1994 PCr: 0.42 ± 0.31%/min, pHj: -0.04 ± 0.20 unit/min) relative to both the control group (ATP: 0.80 ± 0.16%/min, PCr: 0.79 ± 0.20%/min, pHj: 0.32 ± 0.29 unit/min) and the MK-801 group (ATP: 0.70 ± 0.09%/min, PCr: 0.79 ± O.13%/min, pHj: 0.54 ± 0.13 unit/min). pHj became more acidotic during the first 27 min of reperfusion in the control and NBQX groups, whereas it recovered continuously in the MK-801 group. Thefinal recovery of ATP, PCn and pHj were 81.0 ± 19.0%, 95.1 ± 17.7%, and 7.07 ± 0.10, respectively, in the control group, 75.3 ± 8.3%, 87.3 ± 9.6%, and 7.09 ± 0.04, respectively, in the MK-801 group, and 46.4 ± 26.4%, 60.8 ± 46.7%, and 6.61 ± 0.53, respectively, in the NBQX group. The final recovery of ATP (p = 0.025) and pHj (p = 0.026) was significantly reduced in the NBQX group.
Cerebral blood flow and oxygen and glucose metabolism (Table 2, Fig. 3 )
At the normothermic bypass baseline, the cere bral blood flow (p = 0.012) and cerebral oxygen consumption (p = 0.007) were significantly de pressed by both MK-801 and NBQX relative to the control group. Oxygen consumption decreased to 9.5 ± 2.5% of the normothermic baseline in the con trol group, 15.1 ± 5.6% in the MK-801 group, and 9.5 ± 3.8% in the NBQX group after core cooling. In the MK-801 group, although actual cerebral ox ygen consumption remained significantly lower than control at 3 h 45 min reperfusion, both cerebral blood flow and cerebral oxygen consumption recov ered above their own baseline levels (141.7 ± 15.0% and 104.5 ± 29.5% of baseline, respectively). In the NBQX group, cerebral blood flow, cerebral oxygen consumption, and cerebral glucose consumption stayed significantly lower than in the other two groups as they had been at baseline, and both cere bral oxygen consumption and cerebral glucose con sumption ultimately recovered well below their own baseline levels (60.7 ± 22.4% and 24.9 ± 21.1% of baseline, respectively).
Systemic lactate level (Fig. 4) The systemic lactate level was elevated to 6.82 ± 0.81 mmollL (266 ± 39% of baseline) in the control group, 4.87 ± 0.71 mmol/L (259 ± 27% of baseline) in the MK-801 group, and 6.55 ± 1.10 mmollL (262 ± 73% of baseline) in the NBQX group at 5 min of reperfusion. It stayed high in the control group (6.28 ± 1.71 mmollL, 243 ± 66% of baseline) and in the NBQX group (4.91 ± 0.89 mmol/L, 195 ± 46% of baseline), but in the MK-801 group, decreased to a significantly lower level (2.37 ± 0.64 mmollL, 124 ± 22% of baseline). Cerebral arteriovenous (AV) dif ference in lactate was relatively small (mean of 0.44 ± 0.21 mmollL) at all measurements, and no differ ence was measurable in cerebral lactate production rate calculated from the A V difference and the CBF among the groups (data not shown).
Regional blood flow (Fig. 5) The regional blood flow to the kidney (p 0.003), liver (hepatic arterial) (p = 0.025), and adre nal (p = 0.024) was reduced in the NBQX group and the blood flow to the heart (p = 0.027) was reduced in the MK-801 group and in the NBQX group. The regional blood flow to the intestine (p = 0.001) was increased both in the MK-801 and the NBQX groups.
Brain water content
Brain water content at the end of the experiment was lowest in the MK-801 (0.8059 ± 0.0116) and highest in the NBQX group (0.8158 ± 0.0088). It was 0.8124 ± 0. 0047 in the control group (p = 0.036). 
DISCUSSION
This study demonstrates that MK-801 accelerates recovery of cerebral high-energy phosphates and in tracellular pH following 1 h of deep hypothermic circulatory arrest as applied for repair of congenital heart defects. In contrast, at the dose employed in this study, NBQX pretreatment results in severe depression of cerebral metabolic rate and, as well, bral blood flow and cerebral metabolic rate deter mined by oxygen consumption were depressed by both MK-80l and NBQX at baseline relative to con trol.
The. results of these piglet bypass studies suggest a mechanism for recent observations that MK-80l may be useful in decreasing cerebral injury of var ious causes (e.g., Gill et aI., 1987; Kochhar et aI., 1988; Ozyurt et aI., 1988; Albers et aI., 1989; Mel drum, 1990) . Ment et ai. (1989) have described sim ilar findings to those of our study in a canine model of neonatal asphyxia. Newborn dogs were pre treated with 10 mg/kg of MK-80l 15 min before a hypoxic insult. Treated animals had improved re covery of cerebral phosphocreatine, determined by magnetic resonance spectroscopy, as well as less accumulation of cerebral lactate and less intracellu lar acidosis. Haraldseth et ai. (1990) studied acute recovery of cerebral high-energy phosphates using magnetic resonance spectroscopy in rats subjected to 10 min of normothermic global ischemia. They also found improved early recovery with MK-801. Other studies of cerebral ischemia, predominantly in rodent models, also have found improved func tional recovery or reduced histologic evidence of neuronal injury following treatment with MK-80l (Gill et aI., 1987; Meldrum, 1990) . However, Le Blanc et ai. (1991) found that MK-80l was not pro tective in a neonatal piglet model of bilateral carotid artery ligation with hypoxia and hypotension. Care ful control of temperature is necessary in such stud ies because MK-80l may have a direct central ac tion on temperature control (Corbett et aI., 1990) . In a study of closed head injury in rats, Shapira et ai. (1990) found that treatment 1 h post-insult with 3 mg/kg of MK-80l resulted in less cerebral edema at 24 h and improved neurological score at 48 h.
Most previous studies of MK -801 have studied its efficacy at normothermia. Lucas et ai. (1990) , how ever, examined the effect of cultured spinal cord neurons exposed to hypothermia. They found that between 7 and 10°C all neurons became swollen, and following rewarming to normothermia, 74% died. Treatment with MK-80l at 10 j.LM concentra tion minimized dendrosomatic swelling and reduced neuronal mortality from 74 to 10%.
In contrast to the findings of the current study, a number of authors have recently reported that NBQX is useful in decreasing neuronal injury fol lowing either global or focal cerebral ischemia (Sheardown et aI., 1990; Buchan et aI., 1991; Judge et aI., 1991; Le Peillet et aI., 1992; Gill et aI., 1992) . However, these studies were performed in mature rodents at normothermia and did not include the added insults of cardiopulmonary bypass, anticoag-ulation with heparin, and hemodilution. The origi nal report by Sheardown et ai. (1990) describes a high mortality rate in treated animals. We noted a significant fall in blood pressure in several animals following administration of NBQX. In addition, car diac function by simple observation (no specific in dices of cardiac function were measured in the study because the animals remained on cardiopul monary bypass until the end of the study) appeared to deteriorate progressively during the study. This was not observed in the control animals or those treated with MK-801. Nielsen-Kudsk et ai. (1991) reported a study of isolated rabbit hearts treated with NBQX and found no effect on contraction am plitude or velocity of contraction up to a tissue level of 119 j.LM. Although we did not measure tissue levels of NBQX in our study, we did note that all tissues including the heart were heavily stained yel low-orange by the compound. Most other reports of the efficacy of NBQX (in rodents) have described an intraperitoneal dose of 30 mg/kg whereas we used a total dose of 70 mg/kg in the I-month-old miniature pig. However, this dose is diluted by the large prime volume of the cardiopulmonary bypass circuit (750 ml) relative to the small blood volume of the animal (�300 ml).
Buchan et ai. (1991) studied regional cerebral blood flow in rats following a focal cerebral isch emic insult. Treatment with NBQX (30 mg/kg, i.p.) had no effect on regional cerebral blood flow . We also found that cerebral blood flow was not de pressed relative to baseline (although it was de pressed in absolute terms relative to control ani mals) during the reperfusion period in pigs after 1 h of hypothermic circulatory arrest when treated with NBQX. However, neither cerebral oxygen con sumption nor glucose consumption returned to baseline in animals treated with NBQX, suggesting a direct toxic action at the dose employed, similar to the observations of cardiac function. Westergren and Johansson (1992) found that NBQX protected against cerebral edema induced by glutamate in rats. In contrast, treatment with NBQX was asso ciated with worse cerebral edema than that found both in control and MK-80l-treated piglets in our study. Nellgard and Wieloch (1992) found that MK-801 (1 mg/kg) provided no protection whereas NBQX (30 mg/kg) resulted in a 44-69% decr e ase in neuronal damage in the CAl area of the hippocam pus in rats exposed to normothermic carotid artery occlusion plus hypotension.
The different effects of MK-80l and NBQX on the deleterious cerebral effects of profound hypo thermia and global cerebral ischemia in the piglet may be related to different pharmacologic mecha-nisms of these agents' actions. MK-801 is a non competitive N-methyl-D-aspartate (NMDA) recep tor antagonist, which blocks calcium influx trig gered by excitatory transmitters (Wong et aI. , 1986; Choi, 1985) . MK-801 would be expected to be use ful in decreasing the injury resulting from excito toxic levels of glutamate observed after ischemia (Simon et aI., 1984; Rothman and Olney, 1986) . Ev idence supporting the importance of excitotoxicity after deep hypothermic circulatory arrest has re cently been observed in a prospective clinical study at Children's Hospital. Infants and neonates under went 48 h of continuous EEG monitoring after a mean duration of 55 min of deep hypothermic cir culatory arrest. There was a close correlation be tween duration of circulatory arrest and the likeli hood of EEG (and clinically) determined seizures (Jonas et aI., 1992) which might be excitotoxic in origin. Furthermore, preliminary analysis suggests an association between postoperative seizures and impaired developmental assessment performed at 1 year of age.
NBQX is a non-NMDA, or AMPA (a-amino-3hydroxy-5-methyl-4-isoxazole) receptor antagonist (Honore et aI., 1988) . AMPA receptor activation results in depolarization of the cell membrane and an increase in sodium and potassium flux, and can produce excitotoxic neuronal injury in the imma ture brain (Ferriero et aI. , 1989; McDonald et aI. , 1990) . Cardiopulmonary bypass per se has multiple deleterious effects, such as activation of the com plement system and release of multiple interleukins and activation of white cell and endothelial ligands (Kirklin and Barratt-Boyes, 1992) . Many of these factors can be directly cytotoxic, some through mechanisms involving an increase in cell membrane permeability. Perhaps a combination of NBQX and the deleterious effects of bypass results in an exac erbation of these cytotoxic affects, thereby explain ing the protective effects of NBQX seen with non bypass models of cerebral ischemia in contrast to the serious toxic effects seen in our piglet model. It is also possible that the dosage used in our study was excessive, resulting in a direct toxic action of NBQX.
An interesting finding of this study, which con firms observations made previously by our group (Aoki et aI., 1993) and others (Swain et aI., 1991) , is that intracellular pH shifts in an alkaline direction with cooling ( Fig. 2C ). This was observed in the control animals as well as the animals treated with MK-801 and NBQX. The perfusion protocol in this study made no compensation for the natural shift of blood pH in an alkaline direction which occurs with hypothermia ("a stat" strategy). It appears that in-J Cereb Blood Flow Metab, Vol. 14, No. 1, 1994 tracellular mechanisms also did not function to compensate for the alkaline shift associated with hypothermia.
Neurologic injury after repair of congenital heart anomalies remains an important problem (Ferry, 1990) . The findings of this study suggest that MK-801 may be a useful agent in accelerating acute re covery of cerebral metabolism after hypothermic circulatory arrest as is commonly used for cardiac repair in neonates and infants. Survival studies, in cluding behavioral and morphologic outcome vari ables, should be undertaken with this piglet model to study the safety and efficacy of MK-801 or anal ogous drugs in this setting.
